Reported positions
Quarter-end holdings as filed
Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.
Simplify Asset Management Inc.
A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ · methodology §13F ↗
Period
$6.5B
reported valuesum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away
143
positionsALL retained default holdings for this (filer, period), including NULL-value ones
35
new stakespositions with no comparable holding in the prior quarter (kind new), 2026-03-31
34
exitspositions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
Position changes — into 2026-03-31
by shares · Δ value · filing link · how changes are classified §Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
SIMPLIFY EXCHANGE TRADED FUN GOVERNMENT MONEYposition key sid:sec:prov:fd8220aa15407ff2e73fc4a4104b869e · issuer key cusip6:82889N | add | +$238M | +2,389,735 | $4.4B | $4.6B | 43,649,040 | 46,038,775 | |
ISHARES TR CORE S&P500 ETFposition key pos:11149 · issuer key iss:1231 | add | +$21.6M | +82,160 | $692M | $713M | 1,010,106 | 1,092,266 | |
ISHARES TR CORE US AGGBD ETposition key pos:15622 · issuer key iss:1231 | add | +$127M | +1,299,935 | $280M | $407M | 2,800,131 | 4,100,066 | |
SIMPLIFY EXCHANGE TRADED FUN SHORT TERM TREAposition key sid:sec:prov:5230c4769e16e81895b973f4a79a5e96 · issuer key cusip6:82889N | new | +$117M | +5,528,700 | $0 | $117M | — | 5,528,700 | |
SIMPLIFY EXCHANGE TRADED FUN AGGREGATE BOND Eposition key sid:sec:prov:dd77307d4a652ef6e69a19b6b806f956 · issuer key cusip6:82889N | add | +$4.4M | +250,000 | $38.5M | $42.9M | 1,859,127 | 2,109,127 | |
SIMPLIFY EXCHANGE TRADED FUN TREASURY OPT INCposition key sid:sec:prov:8f85d39b213bbb4dfd8343de577a577c · issuer key cusip6:82889N | new | +$40.0M | +1,700,000 | $0 | $40.0M | — | 1,700,000 | |
ISHARES BITCOIN TRUST ETF SHS BEN INTposition key pos:16460 · issuer key iss:1237 CALL | trim | −$10.8M | −25,000 | $40.8M | $29.9M | 800,000 | 775,000 | |
ISHARES BITCOIN TRUST ETF SHS BEN INTposition key pos:16460 · issuer key iss:1237 | trim | −$12.6M | −95,000 | $39.5M | $26.9M | 795,000 | 700,000 | |
UNITED THERAPEUTICS CORP DEL COMposition key pos:15902 · issuer key iss:2217 | add | +$8.7M | +10,412 | $11.6M | $20.3M | 23,839 | 34,251 | |
ALIGN TECHNOLOGY INC COMposition key pos:14931 · issuer key iss:134 | trim | +$1.6M | −297 | $16.7M | $18.3M | 107,194 | 106,897 | |
ELI LILLY & CO COMposition key pos:16757 · issuer key iss:1353 | trim | −$14.7M | −11,276 | $30.1M | $15.4M | 27,979 | 16,703 | |
NOVO-NORDISK A S ADRposition key pos:17747 · issuer key iss:1589 | new | +$12.0M | +327,357 | $0 | $12.0M | — | 327,357 | |
ABBVIE INC COMposition key pos:16392 · issuer key iss:41 | add | +$5.1M | +24,844 | $5.4M | $10.6M | 23,777 | 48,621 | |
JAZZ PHARMACEUTICALS PLC SHS USDposition key pos:15540 · issuer key iss:2545 | trim | −$2.3M | −19,448 | $12.1M | $9.8M | 71,178 | 51,730 | |
PURECYCLE TECHNOLOGIES INC COMposition key pos:14639 · issuer key iss:1779 | trim | −$7.4M | −162,786 | $16.6M | $9.2M | 1,933,564 | 1,770,778 | |
THERMO FISHER SCIENTIFIC INC COMposition key pos:16012 · issuer key iss:2132 | add | +$5.9M | +12,790 | $2.7M | $8.6M | 4,619 | 17,409 | |
GILEAD SCIENCES INC COMposition key pos:11444 · issuer key iss:1008 | add | +$3.9M | +23,866 | $4.6M | $8.5M | 37,479 | 61,345 | |
REGENERON PHARMACEUTICALS COMposition key pos:16027 · issuer key iss:1826 | trim | −$15.6M | −20,253 | $24.0M | $8.4M | 31,153 | 10,900 | |
JOHNSON & JOHNSON COMposition key pos:14474 · issuer key iss:1258 | add | +$3.6M | +11,161 | $4.5M | $8.1M | 21,960 | 33,121 | |
BIOHAVEN LTD COMposition key pos:14561 · issuer key iss:2447 | trim | −$3.2M | −59,802 | $10.8M | $7.6M | 958,202 | 898,400 | |
10X GENOMICS INC CL A COMposition key pos:11213 · issuer key iss:2106 | trim | −$396K | −131,274 | $7.9M | $7.5M | 485,977 | 354,703 | |
3M CO COMposition key pos:11702 · issuer key iss:2135 | add | +$5.7M | +39,756 | $718K | $6.4M | 4,485 | 44,241 | |
WARBY PARKER INC CL A COMposition key pos:13703 · issuer key iss:2301 | trim | −$2.6M | −109,512 | $8.7M | $6.1M | 400,343 | 290,831 | |
DANAHER CORP DEL COMposition key pos:16031 · issuer key iss:709 | trim | −$4.0M | −12,112 | $10.2M | $6.1M | 44,416 | 32,304 | |
BENITEC BIOPHARMA INC COM NEWposition key pos:13249 · issuer key cusip6:08205P | add | +$4.0M | +411,079 | $2.0M | $6.0M | 151,163 | 562,242 | |
AMGEN INC COMposition key pos:12524 · issuer key iss:193 | trim | −$11.6M | −36,506 | $17.1M | $5.6M | 52,350 | 15,844 | |
ASTRAZENECA PLC ORDposition key pos:18610 · issuer key iss:2433 | new | +$5.1M | +25,818 | $0 | $5.1M | — | 25,818 | |
INTUITIVE SURGICAL INC COM NEWposition key pos:17712 · issuer key iss:1213 | trim | −$3.4M | −3,973 | $8.3M | $5.0M | 14,740 | 10,767 | |
SIMPLIFY EXCHANGE TRADED FUN MANAGED FUTURESposition key sid:sec:prov:21817585692c80c2dc34c942b008e7b6 · issuer key cusip6:82889N | new | +$4.6M | +151,381 | $0 | $4.6M | — | 151,381 | |
EYEPOINT INC COM NEWposition key sid:sec:prov:dcfd7178444c2349b987cfc50b6bf1d8 · issuer key cusip6:30233G | trim | −$2.7M | −49,122 | $6.9M | $4.2M | 375,264 | 326,142 | |
TESLA INC COMposition key pos:11199 · issuer key iss:2119 | trim | −$1.7M | −1,749 | $5.8M | $4.1M | 12,843 | 11,094 | |
VANECK BITCOIN ETF SH BEN INTposition key sid:sec:prov:da0f43638da27aaf53a39130ca9f3bde · issuer key cusip6:92189K | add | −$764K | +16,221 | $4.8M | $4.0M | 192,930 | 209,151 | |
CVS HEALTH CORP COMposition key pos:14228 · issuer key iss:489 | trim | −$2.0M | −20,111 | $5.9M | $3.9M | 74,124 | 54,013 | |
VERTEX PHARMACEUTICALS INC COMposition key pos:11430 · issuer key iss:2265 | trim | −$4.4M | −9,556 | $7.9M | $3.5M | 17,492 | 7,936 | |
ALIGNMENT HEALTHCARE INC COMposition key pos:13470 · issuer key iss:135 | trim | −$1.8M | −69,848 | $5.2M | $3.4M | 262,880 | 193,032 | |
RITHM CAPITAL CORP COM NEWposition key pos:17061 · issuer key iss:1557 | add | +$1.9M | +220,000 | $1.3M | $3.2M | 116,593 | 336,593 | |
ESTABLISHMENT LABS HLDGS INC COMposition key sid:sec:prov:7bf59fd7aeffb1ecf2ffdacd97c7e39d · issuer key cusip6:G31249 | trim | −$2.3M | −19,885 | $5.3M | $3.0M | 72,894 | 53,009 | |
PHATHOM PHARMACEUTICALS INC COMposition key sid:sec:prov:7715098c333bbe982e541f4b97bf5506 · issuer key cusip6:71722W | trim | −$2.4M | −59,549 | $5.3M | $2.9M | 321,935 | 262,386 | |
GE HEALTHCARE TECHNOLOGIES I COMMON STOCKposition key pos:17257 · issuer key iss:981 | trim | −$1.6M | −14,768 | $4.4M | $2.8M | 54,028 | 39,260 | |
ABEONA THERAPEUTICS INC COM NEWposition key sid:sec:prov:714d680633cb6e30dfa6e0d524e9cebd · issuer key cusip6:00289Y | add | −$361K | +7,646 | $2.6M | $2.3M | 500,342 | 507,988 | |
CELLDEX THERAPEUTICS INC NEW COM NEWposition key sid:sec:prov:30f8f229420c7a82ec2ecf2f2f622045 · issuer key cusip6:15117B | trim | −$120K | −16,006 | $2.3M | $2.2M | 85,000 | 68,994 | |
MFA FINL INC COMposition key pos:16100 · issuer key iss:1385 | add | +$117K | +6,500 | $1.9M | $2.0M | 202,500 | 209,000 | |
GUARDANT HEALTH INC COMposition key pos:18541 · issuer key iss:1057 | trim | −$1.1M | −8,760 | $3.0M | $1.9M | 29,581 | 20,821 | |
OCULIS HOLDING AG ORDINARY SHARESposition key sid:sec:prov:d3e1798d38ce2deff0ab7c16a87c8200 · issuer key cusip6:H5870P | trim | −$200K | −32,098 | $2.0M | $1.8M | 98,765 | 66,667 | |
WALMART INC COMposition key pos:14365 · issuer key iss:2299 | trim | +$40.7K | −1,277 | $1.7M | $1.8M | 15,494 | 14,217 | |
INSMED INC COM PAR $.01position key pos:15087 · issuer key iss:1181 | trim | −$4.7M | −26,107 | $6.4M | $1.8M | 36,890 | 10,783 | |
PALANTIR TECHNOLOGIES INC CL Aposition key pos:13311 · issuer key iss:1668 | add | −$19.4K | +1,963 | $1.7M | $1.7M | 9,741 | 11,704 | |
ABBOTT LABORATORIES COMposition key pos:13229 · issuer key iss:38 | trim | −$1.1M | −5,824 | $2.7M | $1.6M | 21,330 | 15,506 | |
CISCO SYS INC COMposition key pos:12802 · issuer key iss:588 | trim | −$10.8K | −501 | $1.6M | $1.5M | 20,360 | 19,859 | |
CORCEPT THERAPEUTICS INC COMposition key pos:16992 · issuer key iss:652 | new | +$1.5M | +37,763 | $0 | $1.5M | — | 37,763 | |
KYVERNA THERAPEUTICS INC COMposition key sid:sec:prov:025f5bfc45d0f21f39b99aeb6192bfc1 · issuer key cusip6:501976 | trim | −$314K | −19,233 | $1.8M | $1.5M | 192,339 | 173,106 | |
PACIRA BIOSCIENCES INC COMposition key pos:14271 · issuer key iss:1666 | trim | −$816K | −23,608 | $2.2M | $1.4M | 86,261 | 62,653 | |
INVENTIVA SA ADSposition key sid:sec:prov:36f6260da0bf69546f0e601e6d5bafdc · issuer key cusip6:46124U | trim | −$305K | −109,739 | $1.6M | $1.3M | 337,662 | 227,923 | |
BERKSHIRE HATHAWAY INC DEL CL B NEWposition key pos:12054 · issuer key iss:360 | new | +$1.3M | +2,622 | $0 | $1.3M | — | 2,622 | |
INTERNATIONAL BUSINESS MACHS COMposition key pos:10976 · issuer key iss:1201 | trim | −$276K | −62 | $1.4M | $1.2M | 4,852 | 4,790 | |
EDWARDS LIFESCIENCES CORP COMposition key pos:17342 · issuer key iss:799 | trim | −$521K | −5,260 | $1.6M | $1.1M | 19,338 | 14,078 | |
VIRIDIAN THERAPEUTICS INC COMposition key sid:sec:prov:4b145c10f034612809a5ead021971789 · issuer key cusip6:92790C | trim | −$2.1M | −47,300 | $3.2M | $1.1M | 103,531 | 56,231 | |
ANNALY CAPITAL MANAGEMENT IN COM NEWposition key pos:14067 · issuer key iss:205 | trim | −$736K | −30,252 | $1.8M | $1.0M | 79,655 | 49,403 | |
DYNEX CAP INC COMposition key pos:16685 · issuer key iss:777 | trim | −$422K | −25,421 | $1.5M | $1.0M | 107,000 | 81,579 | |
AGNC INVT CORP COMposition key pos:18075 · issuer key iss:19 | trim | −$324K | −23,552 | $1.4M | $1.0M | 127,037 | 103,485 | |
OXFORD LANE CAP CORP COMposition key sid:sec:prov:1f27284ea5b5b94cc805e6505df2ca0e · issuer key cusip6:691543 | new | +$978K | +100,000 | $0 | $978K | — | 100,000 | |
AQUESTIVE THERAPEUTICS INC COMposition key sid:sec:prov:287679ae59495e28d5c5c22eea9bb86e · issuer key cusip6:03843E | new | +$972K | +234,279 | $0 | $972K | — | 234,279 | |
VOR BIOPHARMA INC COM NEWposition key sid:sec:prov:60242973181bde6041719c13381cdbb1 · issuer key cusip6:929033 | new | +$955K | +53,510 | $0 | $955K | — | 53,510 | |
ZEVRA THERAPEUTICS INC COM NEWposition key pos:14231 · issuer key cusip6:488445 | add | +$558K | +58,265 | $380K | $938K | 42,365 | 100,630 | |
ORCHESTRA BIOMED HLDGS INC COMposition key sid:sec:prov:9f123b52d9dfa5657af06135ef52f112 · issuer key cusip6:68572M | new | +$932K | +219,387 | $0 | $932K | — | 219,387 | |
ARMOUR RESIDENTIAL REIT INC COM SHSposition key sid:sec:prov:366137dddaec73281a91a6f6e86f631c · issuer key cusip6:042315 | trim | −$481K | −24,100 | $1.4M | $899K | 78,000 | 53,900 | |
FULCRUM THERAPEUTICS INC COMposition key sid:sec:prov:b66dc0816f9158ee3c706ae6f74ba1a4 · issuer key cusip6:359616 | trim | −$916K | −43,680 | $1.8M | $890K | 159,674 | 115,994 | |
COMPASS PATHWAYS PLC SPONSORED ADSposition key sid:sec:prov:88f799da4526ad1ae0a440740a6e9c1b · issuer key cusip6:20451W | trim | −$1.1M | −130,948 | $2.0M | $880K | 290,000 | 159,052 | |
EXXON MOBIL CORP COMposition key pos:15436 · issuer key iss:879 | trim | −$119K | −2,987 | $946K | $826K | 7,858 | 4,871 | |
MERCK & CO INC COMposition key pos:18668 · issuer key iss:1461 | new | +$787K | +6,544 | $0 | $787K | — | 6,544 | |
UNITEDHEALTH GROUP INC COMposition key pos:17013 · issuer key iss:2218 | trim | −$32.2M | −96,906 | $32.9M | $785K | 99,807 | 2,901 | |
TREVI THERAPEUTICS INC COMposition key pos:18739 · issuer key iss:2160 | new | +$780K | +65,412 | $0 | $780K | — | 65,412 | |
MASTERCARD INCORPORATED CL Aposition key pos:15086 · issuer key iss:1433 | trim | −$205K | −169 | $968K | $762K | 1,695 | 1,526 | |
OCULAR THERAPEUTIX INC COMposition key sid:sec:prov:26fd673c04b9acd4e799cbdab734d215 · issuer key cusip6:67576A | new | +$762K | +90,000 | $0 | $762K | — | 90,000 | |
QUALCOMM INC COMposition key pos:18448 · issuer key iss:1786 | add | −$206K | +171 | $924K | $718K | 5,403 | 5,574 | |
SAB BIOTHERAPEUTICS INC COM NEWposition key sid:sec:prov:03d750f8ea50214fdbd147c22363d0f6 · issuer key cusip6:78397T | trim | −$61.7K | −20,997 | $779K | $717K | 208,227 | 187,230 | |
COOPER COS INC COMposition key pos:17918 · issuer key iss:650 | trim | −$407K | −3,700 | $1.1M | $711K | 13,642 | 9,942 | |
BOSTON SCIENTIFIC CORP COMposition key pos:14974 · issuer key iss:423 | trim | −$772K | −4,227 | $1.5M | $711K | 15,551 | 11,324 | |
UPSTREAM BIO INC COMposition key sid:sec:prov:1e348df3cde91ba41d5ebeef0c53e107 · issuer key cusip6:91678A | new | +$700K | +77,793 | $0 | $700K | — | 77,793 | |
4D MOLECULAR THERAPEUTICS IN COMposition key sid:sec:prov:adc22e9a1524ab89aa68e69a21eb8d93 · issuer key cusip6:35104E | new | +$656K | +70,430 | $0 | $656K | — | 70,430 | |
PALO ALTO NETWORKS INC COMposition key pos:15667 · issuer key iss:1670 | new | +$636K | +3,967 | $0 | $636K | — | 3,967 | |
PALISADE BIO INC COMposition key sid:sec:prov:fefbed769ea5db09695bd4a0f3004463 · issuer key cusip6:696389 | new | +$613K | +350,000 | $0 | $613K | — | 350,000 | |
INTUIT COMposition key pos:14708 · issuer key iss:1212 | trim | −$360K | −52 | $972K | $612K | 1,468 | 1,416 | |
SERVICENOW INC COMposition key pos:14558 · issuer key iss:1958 | trim | −$341K | −508 | $908K | $567K | 5,929 | 5,421 | |
STRYKER CORPORATION COMposition key pos:16108 · issuer key iss:2049 | trim | −$258K | −624 | $820K | $562K | 2,334 | 1,710 | |
ADOBE INC COMposition key pos:18200 · issuer key iss:72 | new | +$551K | +2,266 | $0 | $551K | — | 2,266 | |
TG THERAPEUTICS INC COMposition key pos:18173 · issuer key iss:2129 | trim | −$159K | −7,184 | $693K | $533K | 23,233 | 16,049 | |
COMCAST CORP NEW CL Aposition key pos:16006 · issuer key iss:625 | new | +$524K | +18,691 | $0 | $524K | — | 18,691 | |
SPOTIFY TECHNOLOGY S A SHSposition key pos:12641 · issuer key iss:2676 | add | −$84.3K | +32 | $605K | $521K | 1,042 | 1,074 | |
KALARIS THERAPEUTICS INC COMposition key pos:12582 · issuer key cusip6:482929 | add | +$335K | +67,352 | $169K | $504K | 20,074 | 87,426 | |
DELL TECHNOLOGIES INC CL Cposition key pos:16616 · issuer key iss:719 | trim | +$37.1K | −639 | $467K | $504K | 3,712 | 3,073 | |
IMMUNIC INC COMposition key sid:sec:prov:4629488a5d372449ffa54969c78cc5e4 · issuer key cusip6:4525EP | new | +$487K | +438,932 | $0 | $487K | — | 438,932 | |
GE AEROSPACE COM NEWposition key pos:13359 · issuer key iss:997 | trim | −$128K | −283 | $601K | $473K | 1,950 | 1,667 | |
COHERUS ONCOLOGY INC COMposition key sid:sec:prov:fb282388a58c6265f871891455dcfcbb · issuer key cusip6:19249H | new | +$428K | +253,140 | $0 | $428K | — | 253,140 | |
WESTERN DIGITAL CORP COMposition key pos:16491 · issuer key iss:2325 | trim | +$132K | −106 | $282K | $415K | 1,639 | 1,533 | |
CATERPILLAR INC COMposition key pos:14306 · issuer key iss:537 | new | +$407K | +574 | $0 | $407K | — | 574 | |
SEAGATE TECHNOLOGY HLDNGS PL ORD SHSposition key pos:16471 · issuer key iss:2609 | trim | +$103K | −41 | $283K | $386K | 1,026 | 985 | |
CADENCE DESIGN SYSTEM INC COMposition key pos:12669 · issuer key iss:493 | trim | −$81.7K | −108 | $466K | $384K | 1,490 | 1,382 | |
HOME DEPOT INC COMposition key pos:11561 · issuer key iss:1122 | trim | −$61.4K | −133 | $399K | $338K | 1,160 | 1,027 | |
APPLIED MATLS INC COMposition key pos:15036 · issuer key iss:226 | trim | +$75.0K | −30 | $258K | $333K | 1,005 | 975 |
80 more changes below.
1–100 of 163 changes
Mark-to-market only (no share change) · 14
Positions whose share count is identical in both quarters; the value changed with price, not with a decision.
Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
SIMPLIFY EXCHANGE TRADED FUN US EQT PLS UPSIDposition key sid:sec:prov:bc203099dd562dca84fe0066cf3da279 · issuer key cusip6:82889N | no change | −$3.9M | 0 | $76.2M | $72.2M | 1,634,812 | 1,634,812 | |
SIMPLIFY EXCHANGE TRADED FUN MULTI QIS ALTERNposition key sid:sec:prov:3866cdbeaa7e0939f80a6c27af74a577 · issuer key cusip6:82889N | no change | −$10.3M | 0 | $56.1M | $45.8M | 3,777,620 | 3,777,620 | |
SIMPLIFY EXCHANGE TRADED FUN NATL MUNI BD ETFposition key sid:sec:prov:e61249e8765535e86320aaf61fbf5b01 · issuer key cusip6:82889N | no change | −$1.3M | 0 | $38.8M | $37.5M | 1,553,376 | 1,553,376 | |
PLAINS GP HLDGS L P LTD PARTNR INT Aposition key pos:14667 · issuer key iss:1730 | no change | +$6.5M | 0 | $24.4M | $30.9M | 1,272,360 | 1,272,360 | |
SIMPLIFY EXCHANGE TRADED FUN NEXT INTANGIBLEposition key sid:sec:prov:d39e2e81a1800861b8cb8e93c9bc783f · issuer key cusip6:82889N | no change | −$2.3M | 0 | $26.7M | $24.4M | 822,303 | 822,303 | |
SIMPLIFY EXCHANGE TRADED FUN TARGET 15 DISTRIposition key sid:sec:prov:d66e83f19dd153f3cba713773a52c67c · issuer key cusip6:82889N | no change | −$1.1M | 0 | $15.8M | $14.7M | 624,406 | 624,406 | |
ACHIEVE LIFE SCIENCE INC COMposition key sid:sec:prov:3404945f22523373b576582309ed1879 · issuer key cusip6:004468 | no change | −$2.4M | 0 | $5.9M | $3.5M | 1,184,512 | 1,184,512 | |
SIMPLIFY EXCHANGE TRADED FUN ANCORATO TARGETposition key sid:sec:prov:7dc96966089082785052611ad55d3150 · issuer key cusip6:82889N | no change | −$346K | 0 | $3.2M | $2.8M | 125,000 | 125,000 | |
SIMPLIFY EXCHANGE TRADED FUN US EQUITY PLUS Mposition key sid:sec:prov:67334ab3196d7a3b8322896a752905e6 · issuer key cusip6:82889N | no change | +$117K | 0 | $2.6M | $2.7M | 100,000 | 100,000 | |
SIMPLIFY EXCHANGE TRADED FUN PIPER SANDLER USposition key sid:sec:prov:1ec38975abbf0ddda890b23bff06c4c2 · issuer key cusip6:82889N | no change | −$88.9K | 0 | $2.7M | $2.6M | 91,464 | 91,464 | |
DELCATH SYS INC COM NEWposition key sid:sec:prov:d5ca5a1167751bce83e8a54f57ca46ed · issuer key cusip6:24661P | no change | −$214K | 0 | $2.6M | $2.4M | 261,126 | 261,126 | |
MILESTONE PHARMACEUTICALS IN COMposition key sid:sec:prov:22b723f52f71593881ef80163fb7daf8 · issuer key cusip6:59935V | no change | −$1.3M | 0 | $3.0M | $1.8M | 1,506,405 | 1,506,405 | |
LEONABIO INC COMposition key sid:sec:prov:b4fb61062116268ce297ca59ebf42283 · issuer key cusip6:04746L | no change | +$405K | 0 | $1.1M | $1.5M | 149,279 | 149,279 | |
CHIMERA INVT CORP COM SHSposition key pos:12192 · issuer key iss:574 | no change | +$6.1K | 0 | $634K | $640K | 51,025 | 51,025 |
Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Changes derive from the aggregate's top-25 slices and keyable positions only; unkeyable holdings are counted in the registry, not differenced. methodology §13F ↗
Book shape
2026-03-31 · concentration · vs tracked median · tick = median- Top-25 concentration
- 97.3%above median 80.0%
- Concentration index
- 5,164 bpsabove median 446 bps
- Positions with value
- 143 / 143median book 97.5 positions
Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.
null-value positions: 0holdings whose <value> did not parse — retained and counted, never zero-filled · top-N share ·§: 97.3% · HHI (bps) ·§: 5,164integer Herfindahl–Hirschman index in basis points over disclosed position values · QoQ moves: 177
Filing history
AVAILABLE QUARTERSPLANNED sector rotation · Congress overlap · signals for this filer
Complete source filings on SEC EDGAR
The complete filing on EDGAR.
The position list above is served from the published Public Filings build — every position this filer reported for the selected quarter, as it reported it. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Serving this list is M2-CONTRACT §3, amended 2026-08-02; §3.1 keeps live EDGAR for filings newer than this build.
Open Simplify Asset Management Inc.'s 13F filings on SEC EDGAR ↗Notes on this data
Share changes
Compare consecutive quarters
Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.
Coverage
A snapshot, not current holdings
Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.
ViewPrior quarter not yet availableThis build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Reported positions — 2026-03-31
1–100 of 129 issuers · $6.5B disclosed value over 143 rows · 0 undisclosed-value rowsEvery row below carries ticker not yet mapped — stated once here rather than repeated on every row.
| KindClassification is not joined into this reported-position view. Use the changed-positions view to compare the two published quarters. | TickerThis list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names. | Issuera position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing | WeightShare of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets. | Valuevalue undisclosed on the filing: retained and counted, excluded from sums, never shown as $0 | Shares | Position changeShare change is available in the separate comparison view; it is not joined into this position list. | Wt | CongressThe congressional transaction join is unavailable in this build. | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | SIMPLIFY EXCHANGE TRADED FUN13 positions · 13 reported rows
| $5.0B | 64,256,964 | — | 76.9% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | ISHARES TR | $1.1B | 5,192,332 | — | 17.2% | — | ||||||||||||||||||||||||||||||||||||||||
| — | IBITverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ISHARES BITCOIN TRUST ETF | $56.8M | 1,475,000 | — | 0.9% | — | ||||||||||||||||||||||||||||||||||||||||
| — | PAGPverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PLAINS GP HLDGS L P PLAINS GP HLDGS L P · LTD PARTNR INT A CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $30.9M | 1,272,360 | — | 0.5% | — | ||||||||||||||||||||||||||||||||||||||||
| — | UTHRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UNITED THERAPEUTICS CORP DEL UNITED THERAPEUTICS CORP DEL · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $20.3M | 34,251 | — | 0.3% | — | ||||||||||||||||||||||||||||||||||||||||
| — | ALGNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ALIGN TECHNOLOGY INC ALIGN TECHNOLOGY INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $18.3M | 106,897 | — | 0.3% | — | ||||||||||||||||||||||||||||||||||||||||
| — | LLYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ELI LILLY & CO ELI LILLY & CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $15.4M | 16,703 | — | 0.2% | — | ||||||||||||||||||||||||||||||||||||||||
| — | NVOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NOVO-NORDISK A S NOVO-NORDISK A S · ADR CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $12.0M | 327,357 | — | 0.2% | — | ||||||||||||||||||||||||||||||||||||||||
| — | ABBVverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ABBVIE INC ABBVIE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $10.6M | 48,621 | — | 0.2% | — | ||||||||||||||||||||||||||||||||||||||||
| — | JAZZverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | JAZZ PHARMACEUTICALS PLC JAZZ PHARMACEUTICALS PLC · SHS USD CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $9.8M | 51,730 | — | 0.2% | — | ||||||||||||||||||||||||||||||||||||||||
| — | PCTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PURECYCLE TECHNOLOGIES INC PURECYCLE TECHNOLOGIES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $9.2M | 1,770,778 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | TMOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | THERMO FISHER SCIENTIFIC INC THERMO FISHER SCIENTIFIC INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $8.6M | 17,409 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | GILDverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GILEAD SCIENCES INC GILEAD SCIENCES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $8.5M | 61,345 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | REGNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | REGENERON PHARMACEUTICALS REGENERON PHARMACEUTICALS · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $8.4M | 10,900 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | JNJverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | JOHNSON & JOHNSON JOHNSON & JOHNSON · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $8.1M | 33,121 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | BIOHAVEN LTD BIOHAVEN LTD · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $7.6M | 898,400 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | TXGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | 10X GENOMICS INC 10X GENOMICS INC · CL A COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $7.5M | 354,703 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | MMMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | 3M CO 3M CO · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $6.4M | 44,241 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | WRBYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WARBY PARKER INC WARBY PARKER INC · CL A COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $6.1M | 290,831 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | DHRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DANAHER CORP DEL DANAHER CORP DEL · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $6.1M | 32,304 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | BENITEC BIOPHARMA INC BENITEC BIOPHARMA INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $6.0M | 562,242 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | AMGNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AMGEN INC AMGEN INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $5.6M | 15,844 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | AZNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ASTRAZENECA PLC ASTRAZENECA PLC · ORD CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $5.1M | 25,818 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | ISRGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTUITIVE SURGICAL INC INTUITIVE SURGICAL INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $5.0M | 10,767 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | EYEPOINT INC EYEPOINT INC · COM NEW CUSIP 30233G209 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $4.2M | 326,142 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | TSLAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TESLA INC TESLA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $4.1M | 11,094 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | VANECK BITCOIN ETF VANECK BITCOIN ETF · SH BEN INT CUSIP 92189K105 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $4.0M | 209,151 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | CVSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CVS HEALTH CORP CVS HEALTH CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $3.9M | 54,013 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | VRTXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $3.5M | 7,936 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | ACHIEVE LIFE SCIENCE INC ACHIEVE LIFE SCIENCE INC · COM CUSIP 004468500 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $3.5M | 1,184,512 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | ALIGNMENT HEALTHCARE INC ALIGNMENT HEALTHCARE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $3.4M | 193,032 | — | 0.1% | — | ||||||||||||||||||||||||||||||||||||||||
| — | RITMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | RITHM CAPITAL CORP RITHM CAPITAL CORP · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $3.2M | 336,593 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | ESTABLISHMENT LABS HLDGS INC ESTABLISHMENT LABS HLDGS INC · COM CUSIP G31249108 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $3.0M | 53,009 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | PHATHOM PHARMACEUTICALS INC PHATHOM PHARMACEUTICALS INC · COM CUSIP 71722W107 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $2.9M | 262,386 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | GEHCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GE HEALTHCARE TECHNOLOGIES I GE HEALTHCARE TECHNOLOGIES I · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $2.8M | 39,260 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | DELCATH SYS INC DELCATH SYS INC · COM NEW CUSIP 24661P807 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $2.4M | 261,126 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | ABEONA THERAPEUTICS INC ABEONA THERAPEUTICS INC · COM NEW CUSIP 00289Y206 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $2.3M | 507,988 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | CELLDEX THERAPEUTICS INC NEW CELLDEX THERAPEUTICS INC NEW · COM NEW CUSIP 15117B202 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $2.2M | 68,994 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | MFAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MFA FINL INC MFA FINL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $2.0M | 209,000 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | GHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GUARDANT HEALTH INC GUARDANT HEALTH INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.9M | 20,821 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | MILESTONE PHARMACEUTICALS IN MILESTONE PHARMACEUTICALS IN · COM CUSIP 59935V107 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.8M | 1,506,405 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | OCULIS HOLDING AG OCULIS HOLDING AG · ORDINARY SHARES CUSIP H5870P102 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.8M | 66,667 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | WMTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WALMART INC WALMART INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.8M | 14,217 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | INSMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INSMED INC INSMED INC · COM PAR $.01 CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.8M | 10,783 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | PLTRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PALANTIR TECHNOLOGIES INC PALANTIR TECHNOLOGIES INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.7M | 11,704 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | ABTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ABBOTT LABORATORIES ABBOTT LABORATORIES · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.6M | 15,506 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | CSCOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CISCO SYS INC CISCO SYS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.5M | 19,859 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | LEONABIO INC LEONABIO INC · COM CUSIP 04746L203 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.5M | 149,279 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | CORTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CORCEPT THERAPEUTICS INC CORCEPT THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.5M | 37,763 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | KYVERNA THERAPEUTICS INC KYVERNA THERAPEUTICS INC · COM CUSIP 501976104 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.5M | 173,106 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | PCRXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PACIRA BIOSCIENCES INC PACIRA BIOSCIENCES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.4M | 62,653 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | INVENTIVA SA INVENTIVA SA · ADS CUSIP 46124U107 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.3M | 227,923 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | BRK-Bverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BERKSHIRE HATHAWAY INC DEL BERKSHIRE HATHAWAY INC DEL · CL B NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.3M | 2,622 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | IBMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTERNATIONAL BUSINESS MACHS INTERNATIONAL BUSINESS MACHS · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.2M | 4,790 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | EWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EDWARDS LIFESCIENCES CORP EDWARDS LIFESCIENCES CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.1M | 14,078 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | VIRIDIAN THERAPEUTICS INC VIRIDIAN THERAPEUTICS INC · COM CUSIP 92790C104 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.1M | 56,231 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | NLYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ANNALY CAPITAL MANAGEMENT IN ANNALY CAPITAL MANAGEMENT IN · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.0M | 49,403 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | DXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DYNEX CAP INC DYNEX CAP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.0M | 81,579 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | AGNCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AGNC INVT CORP AGNC INVT CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $1.0M | 103,485 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | OXFORD LANE CAP CORP OXFORD LANE CAP CORP · COM CUSIP 691543847 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $978K | 100,000 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | AQUESTIVE THERAPEUTICS INC AQUESTIVE THERAPEUTICS INC · COM CUSIP 03843E104 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $972K | 234,279 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | VOR BIOPHARMA INC VOR BIOPHARMA INC · COM NEW CUSIP 929033207 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $955K | 53,510 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | ZEVRA THERAPEUTICS INC ZEVRA THERAPEUTICS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $938K | 100,630 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | ORCHESTRA BIOMED HLDGS INC ORCHESTRA BIOMED HLDGS INC · COM CUSIP 68572M106 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $932K | 219,387 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | ARMOUR RESIDENTIAL REIT INC ARMOUR RESIDENTIAL REIT INC · COM SHS CUSIP 042315705 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $899K | 53,900 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | FULCRUM THERAPEUTICS INC FULCRUM THERAPEUTICS INC · COM CUSIP 359616109 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $890K | 115,994 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | COMPASS PATHWAYS PLC COMPASS PATHWAYS PLC · SPONSORED ADS CUSIP 20451W101 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $880K | 159,052 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | XOMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EXXON MOBIL CORP EXXON MOBIL CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $826K | 4,871 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | MRKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MERCK & CO INC MERCK & CO INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $787K | 6,544 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | UNHverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | UNITEDHEALTH GROUP INC UNITEDHEALTH GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $785K | 2,901 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | TRVIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TREVI THERAPEUTICS INC TREVI THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $780K | 65,412 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | MAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MASTERCARD INCORPORATED MASTERCARD INCORPORATED · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $762K | 1,526 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | OCULAR THERAPEUTIX INC OCULAR THERAPEUTIX INC · COM CUSIP 67576A100 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $762K | 90,000 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | QCOMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | QUALCOMM INC QUALCOMM INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $718K | 5,574 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | SAB BIOTHERAPEUTICS INC SAB BIOTHERAPEUTICS INC · COM NEW CUSIP 78397T202 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $717K | 187,230 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | COOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | COOPER COS INC COOPER COS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $711K | 9,942 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | BSXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BOSTON SCIENTIFIC CORP BOSTON SCIENTIFIC CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $711K | 11,324 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | UPSTREAM BIO INC UPSTREAM BIO INC · COM CUSIP 91678A107 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $700K | 77,793 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | 4D MOLECULAR THERAPEUTICS IN 4D MOLECULAR THERAPEUTICS IN · COM CUSIP 35104E100 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $656K | 70,430 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | CIMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CHIMERA INVT CORP CHIMERA INVT CORP · COM SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $640K | 51,025 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | PANWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PALO ALTO NETWORKS INC PALO ALTO NETWORKS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $636K | 3,967 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | PALISADE BIO INC PALISADE BIO INC · COM CUSIP 696389402 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $613K | 350,000 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | INTUverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INTUIT INTUIT · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $612K | 1,416 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | NOWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SERVICENOW INC SERVICENOW INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $567K | 5,421 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | SYKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | STRYKER CORPORATION STRYKER CORPORATION · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $562K | 1,710 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | ADBEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ADOBE INC ADOBE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $551K | 2,266 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | TGTXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TG THERAPEUTICS INC TG THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $533K | 16,049 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | CMCSAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | COMCAST CORP NEW COMCAST CORP NEW · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $524K | 18,691 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | SPOTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SPOTIFY TECHNOLOGY S A SPOTIFY TECHNOLOGY S A · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $521K | 1,074 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | KALARIS THERAPEUTICS INC KALARIS THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $504K | 87,426 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | DELLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DELL TECHNOLOGIES INC DELL TECHNOLOGIES INC · CL C CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $504K | 3,073 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | IMMUNIC INC IMMUNIC INC · COM CUSIP 4525EP101 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $487K | 438,932 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | GEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GE AEROSPACE GE AEROSPACE · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $473K | 1,667 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | — | COHERUS ONCOLOGY INC COHERUS ONCOLOGY INC · COM CUSIP 19249H103 quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $428K | 253,140 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | WDCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | WESTERN DIGITAL CORP WESTERN DIGITAL CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $415K | 1,533 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | CATverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CATERPILLAR INC CATERPILLAR INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $407K | 574 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | STXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SEAGATE TECHNOLOGY HLDNGS PL SEAGATE TECHNOLOGY HLDNGS PL · ORD SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $386K | 985 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | CDNSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CADENCE DESIGN SYSTEM INC CADENCE DESIGN SYSTEM INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $384K | 1,382 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | HDverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | HOME DEPOT INC HOME DEPOT INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $338K | 1,027 | — | 0.0% | — | ||||||||||||||||||||||||||||||||||||||||
| — | AMATverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | APPLIED MATLS INC APPLIED MATLS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-04-27 +27d | $333K | 975 | — | 0.0% | — |
1–100 of 129 issuers · page 1 of 2
every row this filer reported for the quarter, as it reported it — cross-filer de-duplication is applied to issuer totals elsewhere and never deletes a row here
A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗
13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.
Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.
Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.
Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.
Positions under confidential treatment may be omitted until a later amendment discloses them.
These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).